Google has filed a patent application related to arginine biosynthesis, specifically focusing on a method for producing L-arginine [1]. The application, WO2023214795A1, describes a process utilizing genetically modified microorganisms for this production [1].
What is the specific technology described in the patent?
The patent application details a method for producing L-arginine using engineered Escherichia coli bacteria [1]. This method involves specific genetic modifications to the microorganisms to enhance L-arginine production pathways [1]. The process aims to increase the yield and efficiency of L-arginine synthesis [1].
Who is behind this patent application?
The patent application lists Google LLC as the applicant [1]. This suggests a corporate interest in the technology, potentially for applications in various fields, including nutritional supplements, pharmaceuticals, or industrial biochemical processes.
What are the potential applications of this arginine biosynthesis technology?
L-arginine is an amino acid with several biological functions and applications. It is used in dietary supplements to support cardiovascular health and athletic performance [2]. In medicine, L-arginine can be used to treat conditions like erectile dysfunction and as a component of parenteral nutrition [2]. The patented method could offer a more efficient and sustainable way to produce L-arginine for these markets.
Where can I find more information on drug patents and intellectual property?
Information on drug patents, including applications and granted patents, can be found on resources like DrugPatentWatch.com [3]. This website provides a database of patents related to pharmaceuticals and biotechnology, helping users track intellectual property in the industry [3].